Wells Fargo’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.97K | Sell |
|
|||||
|
2024
Q1 | $21K | Buy |
|
|||||
|
2023
Q4 | $16.9K | Buy |
|
|||||
|
2023
Q3 | $41.7K | Sell |
|
|||||
|
2023
Q2 | $78.3K | Buy |
|
|||||
|
2023
Q1 | $77.5K | Buy |
|
|||||
|
2022
Q4 | $14.1K | Sell |
|
|||||
|
2022
Q3 | $31K | Buy |
|
|||||
|
2022
Q2 | $48K | Sell |
|
|||||
|
2022
Q1 | $2.08M | Sell |
|
|||||
|
2021
Q4 | $2.24M | Sell |
|
|||||
|
2021
Q3 | $14.7M | Buy |
|
|||||
|
2021
Q2 | $7.44M | Buy |
|
|||||
|
2021
Q1 | $2.22M | Buy |
|
|||||
|
2020
Q4 | $2.11M | Buy |
|
|||||
|
2020
Q3 | $1.45M | Buy |
|
|||||
|
2020
Q2 | $1.62M | Buy |
|
|||||
|
2020
Q1 | $1.48M | Sell |
|
|||||
|
2019
Q4 | $2.09M | Buy |
|
|||||
|
2019
Q3 | $1.93M | Buy |
|
|||||
|
2019
Q2 | $1.58M | Buy |
|
|||||
|
2019
Q1 | $1.26M | Buy |
|
|||||
|
2018
Q4 | $920K | Buy |
|
|||||
|
2018
Q3 | $1.34M | Sell |
|
|||||
|
2018
Q2 | $1.73M | Sell |
|
|||||
|
2018
Q1 | $1.23M | Buy |
|
|||||
|
2017
Q4 | $1.09M | Sell |
|
|||||
|
2017
Q3 | $1.28M | Buy |
|
|||||
|
2017
Q2 | $1.25M | Buy |
|
|||||
|
2017
Q1 | $1.09M | Sell |
|
|||||
|
2016
Q4 | $1.39M | Buy |
|
|||||
|
2016
Q3 | $446K | Buy |
|
|||||
|
2016
Q2 | $143K | Buy |
|
|||||
|
2016
Q1 | $145K | Sell |
|
|||||
|
2015
Q4 | $885K | Sell |
|
|||||
|
2015
Q3 | $1.38M | Buy |
|
|||||
|
2015
Q2 | $229K | Sell |
|
|||||
|
2015
Q1 | $161K | Sell |
|
|||||
|
2014
Q4 | $130K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $7K | Sell |
|
|||||
|
2014
Q1 | $10K | Buy |
|